Search | NPA Learn

Diabetes,

Practice update: Being vigilant for hypoglycaemia

The more hypoglycaemic episodes a person experiences, the worse their impaired awareness becomes – so how can pharmacists help to break this cycle?

03 Jul 2024 , 5 Min Article

Diabetes,

Failure to prevent diabetes complications “devastating lives”

Preventable complications are causing “untold hardship” for people with diabetes and costing the UK healthcare system £6.2 billion a year.

19 Jun 2024 , 2 Min Article

Nutrition & weight management,

Nutrition and medicines: part three

Nutrition, medicines and myths: evolution of pharmacy practice.

08 Dec 2023 , 10 Min Module

Diabetes,

New therapies in type 2 diabetes: part two

In her previous article, Samina Ali, a diabetes care specialist pharmacist, considered the role of glucagon-like peptide-1 receptor agonists in type 2 diabetes. Here she concludes this short series on new therapies by looking at the role of sodium-glucose co-transporter-2 inhibitors (SGLT2i)

13 Sep 2023 , 1 Min Article

Diabetes,

New therapies in type 2 diabetes

Following our two-part feature on supporting adults with type 1 diabetes, we turn the spotlight on new therapies for type 2 diabetes. Samina Ali, a diabetes care specialist pharmacist, starts this new series by considering glucagon-like peptide-1 receptor agonists

16 Aug 2023 , 1 Min Article

Diabetes,

Complications of type 1 diabetes

Last month we looked at the management of type 1 diabetes in terms of symptoms and the types of insulin used. Here we turn our attention to disease complications and how pharmacists can support patients living with the condition.

15 Jul 2023 , 1 Min Article

Diabetes,

Supporting adults with type 1 diabetes

This article provides a detailed overview of the management of type 1 diabetes to enable community pharmacists to support patients with the condition.

20 Jun 2023 , 1 Min Article

Public health,

Clinical briefing: Polypharmacy, antidepressants and diabetes

When it comes to antidepressants and type 2 diabetes, polypharmacy does not necessarily undermine adherence. As with so much in medicine and prescribing, the devil is in the detail says Mark Greener

23 Dec 2022 , 1 Min Article